Rakovina Therapeutics Inc. (TSXV:RKV)
Canada · Delayed Price · Currency is CAD 0.2550
+0.0100 (4.08%)
Sep 18, 2026, 3:59 PM EST
Rakovina Therapeutics Market Cap
Rakovina Therapeutics has a market cap or net worth of CAD 11.37 million as of September 18, 2026. Its market cap has increased by 31.13% in one year.
Market Cap
11.37M
Enterprise Value
14.83M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.26
ChartMarket Cap Chart
Since April 1, 2021, Rakovina Therapeutics's market cap has decreased from 14.88M to 11.37M, a decrease of -23.56%. That is a compound annual growth rate of -4.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 11.37M | 437.63% |
| Dec 31, 2025 | 2.11M | -92.08% |
| Dec 31, 2024 | 26.69M | 348.09% |
| Dec 29, 2023 | 5.96M | -52.61% |
| Dec 29, 2022 | 12.57M | -18.16% |
| Dec 31, 2021 | 15.36M | 3.25% |
| Apr 1, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lobe Sciences | 25.47M |
| Devonian Health Group | 23.98M |
| Alzai Health | 23.97M |
| Hemostemix | 15.86M |
| Rapid Dose Therapeutics | 13.64M |
| PreveCeutical Medical | 12.76M |
| Britannia Life Sciences | 11.52M |
| Marvel Biosciences | 9.14M |